Found 7 matching trials
A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198
PHASE2The aim of this phase 2 study is to evaluate the safety and efficacy of sin...
Location
Beijing Ditan Hospital Capital Medical University
A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198
PHASE1This is a phase 1 study in which healthy adult volunteers will receive BRII...
Location
Investigative Site
A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19
PHASE2This study is to evaluate the safety, efficacy and pharmacokinetics profile...
Location
Investigative Site 1
ACTIV-2: A Study for Outpatients With COVID-19
PHASE2Drug studies often look at the effect one or two drugs have on a medical co...
Location
Pinnacle Research Group (Site 1082), 321 E. 10th Street
ACTIV-3: Therapeutics for Inpatients With COVID-19
PHASE3This study looks at the safety and effectiveness of different drugs in trea...
Location
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue
SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine
PHASE4The purpose of this study is to evaluate the safety and efficacy of mRNA CO...
Location
UCLA CARE Center CRS
BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
PHASE3This study looks at the safety and effectiveness of BRII-196/BRII-198 in tr...
Location
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue